Inogen Inc (INGN) - Total Liabilities
Based on the latest financial reports, Inogen Inc (INGN) has total liabilities worth $103.02 Million USD as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore net asset momentum of Inogen Inc to track the company's year-over-year net asset growth rate.
Inogen Inc - Total Liabilities Trend (2011–2025)
This chart illustrates how Inogen Inc's total liabilities have evolved over time, based on quarterly financial data. See Inogen Inc free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Inogen Inc Competitors by Total Liabilities
The table below lists competitors of Inogen Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Melar Acquisition Corp. I Class A Ordinary Shares
NASDAQ:MACI
|
USA | $10.89 Million |
|
Niu Technologies
F:0O9
|
Germany | €2.05 Billion |
|
United Pharm
KO:033270
|
Korea | ₩103.96 Billion |
|
Tele2 AB (publ)
ST:TEL2-A
|
Sweden | Skr41.14 Billion |
|
Gencor Industries Inc
NYSE MKT:GENC
|
USA | $13.67 Million |
|
Bluerock Acquisition Corp. Class A Ordinary Shares
NASDAQ:BLRK
|
USA | $596.17K |
|
La Française de l'Energie S.A.
PA:FDE
|
France | €158.57 Million |
|
Pappajack Bhd
KLSE:0242
|
Malaysia | RM89.58 Million |
Liability Composition Analysis (2011–2025)
This chart breaks down Inogen Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see INGN market cap.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.10 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.56 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.36 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Inogen Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Inogen Inc (2011–2025)
The table below shows the annual total liabilities of Inogen Inc from 2011 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $106.39 Million | -13.02% |
| 2024-12-31 | $122.33 Million | +0.78% |
| 2023-12-31 | $121.38 Million | +12.77% |
| 2022-12-31 | $107.64 Million | -9.77% |
| 2021-12-31 | $119.29 Million | +6.29% |
| 2020-12-31 | $112.23 Million | +9.26% |
| 2019-12-31 | $102.72 Million | +56.88% |
| 2018-12-31 | $65.47 Million | +36.32% |
| 2017-12-31 | $48.03 Million | +50.28% |
| 2016-12-31 | $31.96 Million | +17.09% |
| 2015-12-31 | $27.30 Million | +24.44% |
| 2014-12-31 | $21.93 Million | -15.95% |
| 2013-12-31 | $26.10 Million | +37.28% |
| 2012-12-31 | $19.01 Million | +14.70% |
| 2011-12-31 | $16.57 Million | -- |
About Inogen Inc
Inogen, Inc., a medical technology company, develops, manufactures, and markets respiratory health products in the United States and internationally. The company offers portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. It provides Inogen One and Inogen Rove, an ambulatory solution for long-term oxygen the… Read more